Angela F Koenig1, Sonya Borrero2, Xinhua Zhao3, Lisa Callegari4, Maria K Mor3, Sarita Sonalkar5. 1. Department of Obstetrics and Gynecology, The Hospital of the University of Pennsylvania. Electronic address: angela.koenig@va.gov. 2. VA Center for Health Equity Research and Promotion, VA Pittsburgh Healthcare System; Center for Research on Health Care, University of Pittsburgh School of Medicine. 3. VA Center for Health Equity Research and Promotion, VA Pittsburgh Healthcare System. 4. VA Health Services Research and Development Center of Innovation for Veteran-Centered and Value Driven Care, VA Puget Sound Healthcare System; Department of Obstetrics and Gynecology, University of Washington School of Medicine. 5. Department of Obstetrics and Gynecology, The Hospital of the University of Pennsylvania.
Abstract
OBJECTIVES: The objective of this study is to understand patient-, provider- and system-level factors associated with long-acting reversible contraception (LARC) use among women Veterans and with receipt of LARC methods within the Veterans Affairs (VA) system. STUDY DESIGN: We analyzed data from a national telephone-based survey of 2302 women ages 18-44 receiving primary care in VA. Multivariable regression was used to examine adjusted associations of participant-reported patient-, provider- and facility-level factors with LARC use and within-VA receipt of LARC among women Veterans. RESULTS: Among 987 women Veterans at risk of unintended pregnancy, 294 (30%) reported using LARC, 65% of whom had received their method within VA. Higher LARC use was observed among women who were multiparous vs. nulliparous [adjusted odds ratio (aOR)=1.52; 95% confidence interval (CI)=1.04-2.22] and did not desire future pregnancies (aOR=1.88; 95% CI=1.31-2.68). Although overall LARC uptake was not associated with any provider- or facility-level factors, receipt of these methods within VA was associated with receiving both general and gender-specific health care by a single provider (aOR=2.81; 95% CI=1.20-6.61) and with receiving care within a women's health clinic (aOR=2.54; 95% CI=1.17-5.50). CONCLUSIONS: While patient-level factors were more strongly correlated with use of LARC, provider- and system-level factors influence whether women received these methods within VA. IMPLICATIONS: This study of patient-, provider- and system-level correlates of LARC use in VA, the country's largest integrated healthcare system, highlights that women Veterans share similar patient-level factors associated with LARC use as the general population and that continuity with providers and comprehensive women's health services can facilitate LARC access. Published by Elsevier Inc.
OBJECTIVES: The objective of this study is to understand patient-, provider- and system-level factors associated with long-acting reversible contraception (LARC) use among women Veterans and with receipt of LARC methods within the Veterans Affairs (VA) system. STUDY DESIGN: We analyzed data from a national telephone-based survey of 2302 women ages 18-44 receiving primary care in VA. Multivariable regression was used to examine adjusted associations of participant-reported patient-, provider- and facility-level factors with LARC use and within-VA receipt of LARC among women Veterans. RESULTS: Among 987 women Veterans at risk of unintended pregnancy, 294 (30%) reported using LARC, 65% of whom had received their method within VA. Higher LARC use was observed among women who were multiparous vs. nulliparous [adjusted odds ratio (aOR)=1.52; 95% confidence interval (CI)=1.04-2.22] and did not desire future pregnancies (aOR=1.88; 95% CI=1.31-2.68). Although overall LARC uptake was not associated with any provider- or facility-level factors, receipt of these methods within VA was associated with receiving both general and gender-specific health care by a single provider (aOR=2.81; 95% CI=1.20-6.61) and with receiving care within a women's health clinic (aOR=2.54; 95% CI=1.17-5.50). CONCLUSIONS: While patient-level factors were more strongly correlated with use of LARC, provider- and system-level factors influence whether women received these methods within VA. IMPLICATIONS: This study of patient-, provider- and system-level correlates of LARC use in VA, the country's largest integrated healthcare system, highlights that women Veterans share similar patient-level factors associated with LARC use as the general population and that continuity with providers and comprehensive women's health services can facilitate LARC access. Published by Elsevier Inc.
Authors: Hye-Youn Park; Maria I Rodriguez; Denis Hulett; Philip D Darney; Heike Thiel de Bocanegra Journal: Contraception Date: 2012-05-26 Impact factor: 3.375
Authors: Anita L Nelson; Stephen Cohen; Alex Galitsky; Mark Hathaway; Dale Kappus; Majid Kerolous; Kiren Patel; Linda Dominguez Journal: Contraception Date: 2017-09-25 Impact factor: 3.375
Authors: Cynthia C Harper; Corinne H Rocca; Kirsten M Thompson; Johanna Morfesis; Suzan Goodman; Philip D Darney; Carolyn L Westhoff; J Joseph Speidel Journal: Lancet Date: 2015-06-16 Impact factor: 79.321
Authors: Sonya Borrero; Lisa S Callegari; Xinhua Zhao; Maria K Mor; Florentina E Sileanu; Galen Switzer; Susan Zickmund; Donna L Washington; Laurie C Zephyrin; E Bimla Schwarz Journal: J Gen Intern Med Date: 2017-04-21 Impact factor: 5.128